Radioimmunotherapy Using Vascular Targeted 213Bi: The Role of Tumor Necrosis Factor α in the Development of Pulmonary Fibrosis

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages

  Davis, Ila A ^a   Kennel, Stephen J ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH 213; MONOCLONAL ANTIBODY 201B BI 213; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CARCINOMA; CARCINOMA CELL; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; LIFESPAN; LUNG BLOOD VESSEL; LUNG CARCINOMA; LUNG FIBROSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; VASCULAR ENDOTHELIUM;

ANIMALS; BISMUTH; FEMALE; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PULMONARY FIBROSIS; RADIOIMMUNOTHERAPY; THROMBOMODULIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032697129     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brooks, P. C., Clark, R. A. F., and Cheresh, D. A. Requirement of vascular integrin αVβ3 for angiogenesis. Science (Washington DC), 264: 569-571, 1994.
2. Rüegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P., and Lejeune, F. J. Evidence for the involvement of endothelial cell integrin αVβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat. Med., 4: 408-414, 1998.
3. Soker, S., Takashima, S., Miao, H. Q., Neufeld, G., and Klagsburn, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 92: 735-745, 1998.
4. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.
5. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
6. Burrows, F. J., and Thorpe, P. E. Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature. Proc. Natl. Acad. Sci. USA, 90: 8996-9000, 1993.
7. Ran, S., Gao, B., Duffy, S., Watkins, L., Rote, N., and Thorpe, P. E. Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to solid tumor vasculature. Cancer Res., 58: 4646-4653, 1998.
8. Huang, X., Molema, G., King, S., Watkins, L., Edgington, T. S., and Thorpe, P. E. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science (Washington DC), 275: 547-550, 1997.
9. Kennel, S. J., and Mirzadeh, S. Vascular targeting for radioimmunotherapy with. 213Bi. Radiochim. Acta, 79: 87-91, 1997.
10. Boll, R. A., Mirzadeh, S., and Kennel, S. J. Optimizing of radiolabeling of immunoproteins with. 213Bi. Radiochim. Acta, 79: 145-149, 1997.
11. Kennel, S. J., Boll, R., Stabin, M., Schuller, H. M., and Mirzadeh, S. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi. Br. J. Cancer, 80: 175-184, 1999.
12. Kennel, S. J., and Mirzadeh, S. Vascular targeted radioimmunotherapy with 213Bi-An α-particle emitter. Nucl. Med. Biol., 25: 241-246, 1998.
13. Nonn, R. A., and Gross, N. J. Effects of radiation on the lung. Curr. Opin. Pulm. Med., 2: 390-395, 1996.
14. Alberts, W. M. Pulmonary complications of cancer treatment. Curr. Opin. Oncol., 9: 161-169, 1997.
15. Johnston, C. J., Piedboeuf, B., Rubin, P., Williams, J. P., Baggs, R., and Finkelstein, J. N. Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat. Res., 145: 762-767, 1996.
16. Franko, A. J., Sharplin, J., Ghahary, A., and Barcellos-Hoff, M. H. Immunohistochemical localization of transforming growth factor beta and tumor necrosis factor alpha in the lungs of fibrosis-prone and “non-fibrosing” mice during the latent period and early phase after irradiation. Radiat. Res., 147: 245-256, 1997.
17. Sueoka, N., Sueoka, E., Miyazaki, Y., Okabe, S., Kurosumi, M., Takayama, S., and Fujiki, H. Molecular pathogenesis of interstitial pneumonitis with TNF-alpha transgenic mice. Cytokine, 10: 124-131, 1998.
18. Eugster, H. P., Muller, M., Karrer, U., Car, B. D., Schnyder, B., Eng, V. M., Woerly, G., Le Hir, M., di Padova, F., Aguet, M., Zinkernagel, R., Bluethmann, H., and Ryffel, B. Multiple immune abnormalities in tumor necrosis factor and lymphotoxin-alpha double deficient mice. Int. Immunol., 8: 23-26, 1996.
19. Kennel, S. J., Lankford, T. K., Ullrich, R. L., and Jamasbi, R. J. Enhancement of lung tumor colony formation by treatment of mice with monoclonal antibodies to pulmonary capillary endothelial cells. Cancer Res., 48: 4964-4968, 1988.
20. Hughes, B. J., Kennel, S., Lee, R., and Huang, L. Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res., 49: 6214-6220, 1989.
21. Kennel, S. J., Lee, R., Bultman, S., Kabalka, G. Rat monoclonal antibody distribution in mice: an epitope inside the lung vascular space mediates very efficient localization. Nucl. Med. Biol., 17: 193-200, 1990.
22. Brechbiel, M. W., and Gansow, O. A. Synthesis of C-functionalized trans-cyclohexyldiethylenetriaminepenta-acetic acids for labeling of monoclonal antibodies with the bismuth-212 α particle emitter. J. Chem. Soc. Perkin Trans., 1: 1173-1178, 1992.
23. Fisher, C. J., Opal, S. M., Dhainaut, J. F., and Stephens, S. Influence of anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. Crit. Care Med., 21: 318-337, 1993.
24. Kuby, J. Cells and organs of the immune system. In: J. Kuby (ed.), Immunology, Ed. 2, pp. 47-84. New York: W. H. Freeman and Co., 1994.